Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 909 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Adding Retifanlimab To Chemotherapy Provides OS Benefit over Chemotherapy In First-Line... May 18, 2026 Vaping Pods Produce High Nicotine Levels in Young Users October 5, 2018 2022 ASCO Annual Meeting Research Round Up: Advances in Treating Multiple... July 28, 2022 Long-Term Outcomes in Patients with Metastatic Melanoma Treated with Anti-PD1 Therapy... October 28, 2021 Load more HOT NEWS FDA Approves Pembrolizumab with Chemotherapy for HER2-negative Gastric or Gastro-Oesophageal Junction... New Vaccine Stimulates Survivors’ Immune Systems to Keep Triple-Negative Cancer from... Targeted Radiation Reduces Pain from Cancer Metastases in the Spine Complete Cancer Prevalence in Europe in 2020 Reveals an Increased Proportion...
